SANAM MOBIN: Open Payments
NPI 1952822439 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 6 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $50 · 2025 $269
Education: $183Food & beverage: $86
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $160 |
| AstraZeneca Pharmaceuticals LP | 2 | $109 |
Products named: Enhertu, LYNPARZA.
Industry payments across CA — which companies pay providers there.
